Marama Labs

📍 Dublin, Ireland🗓 Founded 2017👥 20 employees💰 Last funded Dec 2023
Biotechnology Research🌐 maramalabs.com
Website LinkedIn
MaramaLabs’ CloudSpec instrument has a valuable capability for UV-Vis analysis – it can measure through cloudy liquids. If you think of all the liquids you encounter daily you will begin to appreciate how much of a stumbling block this is for UV-Vis. CloudSpec’s novel ability – scatter-corrected absorption (SCA) spectroscopy – enables quantitative analysis of the constituents of cloudy liquids quickly and easily. CloudSpec is a perfect fit for nanomedicine development, manufacturing and quality control. Nanomedicines are too small to see but they protect and deliver new classes of drugs – vaccines, oncological treatments, gene therapies and more – safely and effectively into the body. With CloudSpec, drug developers can quantify potency in seconds, accurately and easily, for substantial time and cost savings.
2
Total investors
0
Early stage
1
Mid stage
0
Late stage
2017
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography2 countries
Ireland
1
United States
1
Frequently asked questions
Who invested in Marama Labs?
Marama Labs has 2 investors on record on gritt.io, 1 mid-stage.
When did Marama Labs last raise funding?
The most recent investment in Marama Labs recorded on gritt.io was in December 2023.
When was Marama Labs founded?
Marama Labs was founded in 2017.
What industry is Marama Labs in?
Marama Labs operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Marama Labs based?
Marama Labs is headquartered in Dublin, Ireland.